問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberCTQJ230A12301
Active

2020-06-15 - 2026-12-31

Phase III

Not yet recruiting4

Recruiting8

ICD-10I25.10

Atherosclerotic heart disease of native coronary artery without angina pectoris

ICD-9429.2

Cardiovascular disease, unspecified

  • Trial Applicant

    NOVARTIS (TAIWAN) CO., LTD.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Kuan-Cheng Chang Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 翁國昌 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 蘇峻弘 Division of Cardiovascular Diseases
  • 蔡青風 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Shih-Hsien Sung Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator I-Chang Hsieh Division of Cardiovascular Diseases

Co-Principal Investigator

  • 陳俊吉 Division of Cardiovascular Diseases
  • 謝明哲 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 劉銘恩 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 楊翔惟 Division of Cardiovascular Diseases
  • 劉俞旻 Division of Cardiovascular Diseases
  • 林柏霖 Division of Cardiovascular Diseases
  • 吳敘平 Division of Cardiovascular Diseases
  • 賴堯暉 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 張瑋婷 Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 曹玄明 未分科

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Tsung-Hsien Lin Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 鄭正一 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 薛書凱 Division of Cardiovascular Diseases
  • 陳建仁 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 曹玄明 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 陳思穎 Division of Cardiovascular Diseases
  • 廖照峰 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 陳韋翔 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 王兆宏 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    120 participants

  • Global

    8280 participants